Key Development
Hai Phong Eye Hospital officially opened its International Eye Department on October 9, 2026, less than a year after being upgraded to a Level I specialty hospital and only months after launching a high-quality refractive-surgery center. The sequence suggests a broader strategy: moving beyond basic capacity expansion toward differentiated ophthalmology service lines.
The new department includes expert clinics for adults and children, consultations covering refractive, aesthetic and general eye-care services, plus optical and pharmacy functions. It is connected to the hospital’s other campuses for access to Phaco surgery, refractive procedures and higher-complexity ophthalmic care. The hospital also maintains cooperation with the Asia Prevention of Blindness Association around training, consultation and vitreoretinal treatment, with plans for deeper technical exchange involving Japanese partners.
Why It Matters
- The hospital already has sufficient scale to build specialty platforms. In 2025 it recorded approximately 86,500 visits, 16,300 inpatient episodes and 13,000 surgeries, including about 10,000 cataract procedures.
- Underlying demand continues to rise. WHO estimates at least 2.2 billion people globally live with vision impairment, with refractive error and cataract among the leading causes.
- Hai Phong is adding higher-value services such as refractive surgery, expert consultation and advanced retinal care to a strong cataract base.
- International partnerships can differentiate clinical capability, but only when they translate into skills, protocols and outcomes rather than branding alone.
Healthcare Insight Analysis
Healthcare Insight believes the strategic concept is service segmentation.
A public eye hospital increasingly needs to solve two different problems.
The first is population eye health:
refractive error → cataract → glaucoma → diabetic retinopathy → blindness prevention.
This requires scale, affordability and high throughput.
The second is high-complexity and higher-value ophthalmology:
refractive surgery → vitreoretinal disease → pediatric ophthalmology → advanced diagnostics → expert-led care.
That requires technology, specialized clinicians and a more sophisticated care experience.
Creating distinct service layers does not necessarily mean abandoning the public mission.
Done well, it can help a specialty hospital retain complex patients locally, improve equipment utilization and diversify professional revenue streams. Hai Phong Eye Hospital’s own 2026 priorities include building regional specialty centers, expanding digital transformation and improving financial autonomy.
But the word “international” must ultimately be defined by clinical standards rather than upgraded facilities.
A differentiated model needs to demonstrate:
diagnostic accuracy → time-to-treatment → complication rate → visual outcome → patient-reported outcome.
This matters particularly in cataract and refractive surgery because advanced hardware is increasingly replicable.
Hai Phong introduced the SCHWIND ATOS and SCHWIND AMARIS ecosystem in its refractive center in June 2026.
Yet equipment itself is unlikely to be a durable moat.
The stronger moat is:
surgeon volume + clinical protocols + outcomes data + referral network + international knowledge transfer.
This is why collaboration with APBA and Japanese institutions may ultimately matter more than the department’s branding.
If cooperation produces fellowships, difficult-case consultations, vitreoretinal capability transfer and joint research, the hospital accumulates knowledge that competitors cannot reproduce simply by purchasing similar devices.
There is also an important balancing risk.
Premium services should not pull scarce clinicians or operating-room capacity away from essential eye care.
WHO estimates that at least 1 billion cases of vision impairment worldwide could have been prevented or remain unaddressed, while uncorrected refractive error and cataract remain major causes of avoidable impairment.
The strongest model is therefore not to premiumize the entire institution.
It is to use segmentation to expand both access and specialization.
That model could also strengthen regionalization.
If patients from Hai Phong and surrounding northern coastal provinces can obtain complex retinal treatment, pediatric specialist consultation or modern refractive surgery locally, the hospital may reduce the need for some patients to travel to Hanoi or seek private alternatives elsewhere.
That remains a strategic possibility rather than a demonstrated outcome, and referral data will be needed to prove it.
Market Implications
Public specialty hospitals: competition can move beyond volume toward differentiated clinical service lines.
Private ophthalmology: competition may intensify as public hospitals invest more aggressively in refractive surgery, patient experience and specialist care.
Medtech: demand broadens from cataract equipment into refractive platforms, retinal imaging, diagnostics and lifecycle services.
International training: becomes a strategic asset when it generates new procedures, research and measurable clinical performance.
ANALYTICAL MATRIX
| Dimension | Current Base | Opportunity | KPI to Watch |
| Volume | 86,500 visits in 2025 | Regional referral hub | Referral inflow |
| Cataract | ~10,000 procedures | Scale and efficiency | Visual outcome |
| Refractive | New center in 2026 | Higher-value service | Satisfaction, retreatment |
| International | APBA + Japanese links | Capability transfer | New techniques adopted |
| Financial model | Autonomy priority | Revenue diversification | Revenue/clinical capacity |
The real milestone is therefore not that Hai Phong now has another department carrying the word “International.”
The more important question is whether it becomes a sufficiently capable specialty platform that allows patients in the northern coastal region to access advanced eye care closer to home without weakening the hospital’s population-level eye-care mission.
If Hai Phong can achieve both, this may become a useful example of how a public specialty hospital evolves from a high-volume provider into a regional specialty platform.